Is Inhibrx Biosciences Inc. overvalued?

Inhibrx Biosciences Inc. (INBX) — key valuation metrics and fundamentals.

No verdict

Price

$88.37

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$1.30B

Dividend yield

0.9%

Return on equity

-563.9%

Sector

Healthcare

Fair value compares INBX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks